GlassScriptPhysician profile
Cornelia S De Riese
NPI 1841280716
$2,629.24
in general payments reported to CMS, 2019-2025
8 companies · $649 in 2025
The $649 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $433 · 2022: $51.24 · 2023: $136 · 2024: $1,360 · 2025: $649.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,635 · Food and Beverage: $510.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,635.18 |
| Food and Beverage | $509.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $1,964.41 | 2024-2025 | |
| Therapeuticsmd, INC. | $231.92 | 2019 | |
| Hologic Sales and Service, LLC | $118.90 | 2019 | |
| Intuitive Surgical, INC. | $95.25 | 2023 | Da Vinci Surgical System |
| Allergan, INC. | $82.23 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $80.42 | 2022-2024 | |
| Ethicon US, LLC | $34.35 | 2022 | |
| Smith+Nephew, INC. | $21.76 | 2025 | Pico 7 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cornelia De Riese listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.